-
1
-
-
84863320414
-
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: Two-year results
-
Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group
-
Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. 2012;119: 1388–1398.
-
(2012)
Ophthalmology
, vol.119
, pp. 1388-1398
-
-
Martin, D.F.1
Maguire, M.G.2
-
2
-
-
84868208071
-
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: Three-year randomized trial results
-
Diabetic Retinopathy Clinical Research Network
-
Diabetic Retinopathy Clinical Research Network, Elman MJ, Qin H, et al. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology. 2012;119:2312–2318.
-
(2012)
Ophthalmology
, vol.119
, pp. 2312-2318
-
-
Elman, M.J.1
Qin, H.2
-
3
-
-
84862817252
-
Ranibizumab for macular edema due to retinal vein occlusions: Long-term follow-up in the HORIZON trial
-
Heier JS, Campochiaro PA, Yau L, et al. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Ophthalmology. 2012;119:802–809.
-
(2012)
Ophthalmology
, vol.119
, pp. 802-809
-
-
Heier, J.S.1
Campochiaro, P.A.2
Yau, L.3
-
4
-
-
20144372969
-
Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: Twelve-week results of an uncontrolled open-label clinical study
-
Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twelve-week results of an uncontrolled open-label clinical study. Ophthalmology. 2005;112:1035–1047.
-
(2005)
Ophthalmology
, vol.112
, pp. 1035-1047
-
-
Michels, S.1
Rosenfeld, P.J.2
Puliafito, C.A.3
Marcus, E.N.4
Venkatraman, A.S.5
-
5
-
-
20144368709
-
Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration
-
Rosenfeld PJ, Schwartz SD, Blumenkranz MS, et al. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Ophthalmology. 2005;112:1048–1053.
-
(2005)
Ophthalmology
, vol.112
, pp. 1048-1053
-
-
Rosenfeld, P.J.1
Schwartz, S.D.2
Blumenkranz, M.S.3
-
6
-
-
33645641520
-
Ranibizumab for treatment of neovascular age-related macular degeneration: A phase I/II multicenter, controlled, multidose study
-
Heier JS, Antoszyk AN, Pavan PR, et al. Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. Ophthalmology. 2006;113:633.e1–e4.
-
(2006)
Ophthalmology
, vol.113
-
-
Heier, J.S.1
Antoszyk, A.N.2
Pavan, P.R.3
-
7
-
-
79956218863
-
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
-
CATT Research Group
-
CATT Research Group, Martin DF, Maguire MG, et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011;364:1897–1908.
-
(2011)
N Engl J Med
, vol.364
, pp. 1897-1908
-
-
Martin, D.F.1
Maguire, M.G.2
-
8
-
-
42549140659
-
Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection
-
Mason JO 3rd, White MF, Feist RM, et al. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection. Retina. 2008;28:564–567.
-
(2008)
Retina
, vol.28
, pp. 564-567
-
-
Mason, J.O.1
White, M.F.2
Feist, R.M.3
-
9
-
-
58949083350
-
Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab
-
Fintak DR, Shah GK, Blinder KJ, et al. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina. 2008;28:1395–1399.
-
(2008)
Retina
, vol.28
, pp. 1395-1399
-
-
Fintak, D.R.1
Shah, G.K.2
Blinder, K.J.3
-
10
-
-
84862914622
-
Avastin doesn’t blind people, people blind people
-
Gonzalez S, Rosenfeld PJ, Stewart MW, Brown J, Murphy SP. Avastin doesn’t blind people, people blind people. Am J Ophthalmol. 2012; 153:196–203. e1.
-
(2012)
Am J Ophthalmol
, vol.153
-
-
Gonzalez, S.1
Rosenfeld, P.J.2
Stewart, M.W.3
Brown, J.4
Murphy, S.P.5
-
11
-
-
84880314430
-
An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone
-
Sheyman AT, Cohen BZ, Friedman AH, Ackert JM. An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone. JAMA Ophthalmol. 2013;131: 864–869.
-
(2013)
JAMA Ophthalmol
, vol.131
, pp. 864-869
-
-
Sheyman, A.T.1
Cohen, B.Z.2
Friedman, A.H.3
Ackert, J.M.4
-
12
-
-
84929600529
-
-
CDC responds to multistate outbreak of fungal meningitis and other infections, Accessed July 30, 2013
-
Centers for Disease Control and Prevention. CDC responds to multistate outbreak of fungal meningitis and other infections. 2012. Available from: http://www.cdc.gov/HAI/outbreaks/currentsituation. Accessed July 30, 2013.
-
(2012)
-
-
-
13
-
-
84929600530
-
-
Severe intraocular inflammation/endophthalmitis following off-label treatment with intravitreal bevacizumab, Accessed January 8, 2015
-
Alan R, Berger SS. Severe intraocular inflammation/endophthalmitis following off-label treatment with intravitreal bevacizumab. 2009. Available from: http://ophthalmologyrounds.ca/modules/contentManager/upload/document/alwaysOnLine/ScientificUpdate_en.pdf. Accessed January 8, 2015.
-
(2009)
-
-
Alan, R.1
Berger, S.S.2
-
14
-
-
77949369713
-
Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch
-
Yamashiro K, Tsujikawa A, Miyamoto K, et al. Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch. Retina. 2010;30:485–490.
-
(2010)
Retina
, vol.30
, pp. 485-490
-
-
Yamashiro, K.1
Tsujikawa, A.2
Miyamoto, K.3
-
15
-
-
54949136462
-
Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration
-
Wickremasinghe SS, Michalova K, Gilhotra J, et al. Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration. Ophthalmology. 2008; 115:1911–1915.
-
(2008)
Ophthalmology
, vol.115
, pp. 1911-1915
-
-
Wickremasinghe, S.S.1
Michalova, K.2
Gilhotra, J.3
-
16
-
-
84873306782
-
Acute intraocular inflammation caused by endotoxin after intravitreal injection of counterfeit bevacizumab in Shanghai, China
-
Wang F, Yu S, Liu K, et al. Acute intraocular inflammation caused by endotoxin after intravitreal injection of counterfeit bevacizumab in Shanghai, China. Ophthalmology. 2013;120:355–361.
-
(2013)
Ophthalmology
, vol.120
, pp. 355-361
-
-
Wang, F.1
Yu, S.2
Liu, K.3
-
17
-
-
84862907626
-
An outbreak of Streptococcus endophthalmitis after intravitreal injection of bevacizumab
-
Goldberg RA, Flynn HW Jr, Isom RF, Miller D, Gonzalez S. An outbreak of Streptococcus endophthalmitis after intravitreal injection of bevacizumab. Am J Ophthalmol. 2012;153:204–208. e1.
-
(2012)
Am J Ophthalmol
, vol.153
-
-
Goldberg, R.A.1
Flynn, H.W.2
Isom, R.F.3
Miller, D.4
Gonzalez, S.5
-
18
-
-
82155185321
-
Acute intraocular inflammation following intravitreal injection of bevacizumab–a large cluster of cases
-
Fielden M, Nelson B, Kherani A. Acute intraocular inflammation following intravitreal injection of bevacizumab–a large cluster of cases. Acta Ophthalmol. 2011;89:e664–e665.
-
(2011)
Acta Ophthalmol
, vol.89
, pp. e664-e665
-
-
Fielden, M.1
Nelson, B.2
Kherani, A.3
-
19
-
-
79955066891
-
Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: Causative organisms and possible prevention strategies
-
McCannel CA. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina. 2011;31:654–661.
-
(2011)
Retina
, vol.31
, pp. 654-661
-
-
McCannel, C.A.1
-
20
-
-
83455236535
-
Bacterial dispersal associated with speech in the setting of intravitreous injections
-
Wen JC, McCannel CA, Mochon AB, Garner OB. Bacterial dispersal associated with speech in the setting of intravitreous injections. Arch Ophthalmol. 2011;129:1551–1554.
-
(2011)
Arch Ophthalmol
, vol.129
, pp. 1551-1554
-
-
Wen, J.C.1
McCannel, C.A.2
Mochon, A.B.3
Garner, O.B.4
-
21
-
-
84861332315
-
Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: Clinical features, causative organisms and post-treatment outcomes
-
Simunovic MP, Rush RB, Hunyor AP, Chang AA. Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol. 2012;96:862–866.
-
(2012)
Br J Ophthalmol
, vol.96
, pp. 862-866
-
-
Simunovic, M.P.1
Rush, R.B.2
Hunyor, A.P.3
Chang, A.A.4
-
22
-
-
80052440649
-
Endophthalmitis after intravitreal injection: The importance of viridans streptococci
-
Chen E, Lin MY, Cox J, Brown DM. Endophthalmitis after intravitreal injection: the importance of viridans streptococci. Retina. 2011;31: 1525–1533.
-
(2011)
Retina
, vol.31
, pp. 1525-1533
-
-
Chen, E.1
Lin, M.Y.2
Cox, J.3
Brown, D.M.4
-
23
-
-
84862167878
-
Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics
-
Bhavsar AR, Stockdale CR, Ferris FL 3rd, Brucker AJ, Bressler NM, Glassman AR. Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics. Arch Ophthalmol. 2012;130:809–810.
-
(2012)
Arch Ophthalmol
, vol.130
, pp. 809-810
-
-
Bhavsar, A.R.1
Stockdale, C.R.2
Ferris, F.L.3
Brucker, A.J.4
Bressler, N.M.5
Glassman, A.R.6
-
24
-
-
84864458918
-
Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections
-
Cheung CS, Wong AW, Lui A, Kertes PJ, Devenyi RG, Lam WC. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology. 2012;119:1609–1614.
-
(2012)
Ophthalmology
, vol.119
, pp. 1609-1614
-
-
Cheung, C.S.1
Wong, A.W.2
Lui, A.3
Kertes, P.J.4
Devenyi, R.G.5
Lam, W.C.6
-
25
-
-
80055089414
-
Prophylactic antibiotic use after intravitreal injection: Effect on endophthalmitis rate
-
Bhatt SS, Stepien KE, Joshi K. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate. Retina. 2011;31:2032–2036.
-
(2011)
Retina
, vol.31
, pp. 2032-2036
-
-
Bhatt, S.S.1
Stepien, K.E.2
Joshi, K.3
-
26
-
-
79959951105
-
Ophthalmic antibiotics and antimicrobial resistance: A randomized, controlled study of patients undergoing intravitreal injections
-
Kim SJ, Toma HS. Ophthalmic antibiotics and antimicrobial resistance: a randomized, controlled study of patients undergoing intravitreal injections. Ophthalmology. 2011;118:1358–1363.
-
(2011)
Ophthalmology
, vol.118
, pp. 1358-1363
-
-
Kim, S.J.1
Toma, H.S.2
-
27
-
-
0035119274
-
Antibiotic resistance pattern and visual outcome in experimentally-induced Staphylococcus epidermidis endophthalmitis in a rabbit model
-
Miño De Kaspar H, Hoepfner AS, Engelbert M, et al. Antibiotic resistance pattern and visual outcome in experimentally-induced Staphylococcus epidermidis endophthalmitis in a rabbit model. Ophthalmology. 2001;108:470–478.
-
(2001)
Ophthalmology
, vol.108
, pp. 470-478
-
-
Miño De Kaspar, H.1
Hoepfner, A.S.2
Engelbert, M.3
-
28
-
-
84869867264
-
Intravitreal injections: Is there benefit for a theatre setting?
-
Abell RG, Kerr NM, Allen P, Vote BJ. Intravitreal injections: is there benefit for a theatre setting? Br J Ophthalmol. 2012;96:1474–1478.
-
(2012)
Br J Ophthalmol
, vol.96
, pp. 1474-1478
-
-
Abell, R.G.1
Kerr, N.M.2
Allen, P.3
Vote, B.J.4
-
29
-
-
84878590351
-
Citation of previous meta-analyses on the same topic: A clue to perpetuation of incorrect methods?
-
Li T, Dickersin K. Citation of previous meta-analyses on the same topic: a clue to perpetuation of incorrect methods? Ophthalmology. 2013;120: 1113–1119.
-
(2013)
Ophthalmology
, vol.120
, pp. 1113-1119
-
-
Li, T.1
Dickersin, K.2
|